Inventor · disambiguated record
Yaoxing Huang
Also filed as: HUANG YAOXING
10 granted patents·8 pending applications·40 citations·filing 2003–2024
85Inventor score
Top patents by PatentIndex Score
18 records- 0190US8637024B2Fusion antibodies for HIV therapyHO DAVID·Filed 2011·Granted Jan 28, 2014·14 cites·29 claims
- 0286US7981428B2Flu vaccines and methods of use thereofACADEMIA SINICA·Filed 2009·Granted Jul 19, 2011·7 cites·17 claims
- 0381US10308707B2Bispecific HIV-1-neutralizing antibodiesAARON DIAMOND AIDS RES CENTER·Filed 2017·Granted Jun 4, 2019·2 cites·5 claims
- 0477US8030029B2Flu vaccines and methods of use thereofACADEMIA SINICA·Filed 2008·Granted Oct 4, 2011·1 cites·5 claims
- 0573US9587012B2Bispecific HIV-1 neutralizing antibodiesAARON DIAMOND AIDS RES CENTER·Filed 2014·Granted Mar 7, 2017·2 cites·10 claims
- 0671US9884905B2Bispecific HIV-1 neutralizing antibodiesAARON DIAMOND AIDS RES CENTER·Filed 2017·Granted Feb 6, 2018·1 cites·6 claims
- 0768US2025026796A1Inhibitory peptides against coronavirusesUNIV COLUMBIA·Filed 2024·Application pending·0 cites
- 0866US7771726B2Use of synthetic glycolipids as universal adjuvants for vaccines against cancer and infectious diseasesUNIV NEW YORK·Filed 2004·Granted Aug 10, 2010·12 cites·38 claims
- 0965US2024002476A1Potent neutralizing antibodies against sars-cov-2, generation and uses thereofUNIV COLUMBIA·Filed 2021·Application pending·0 cites
- 1065US2023203134A1Potent neutralizing antibodies against sars-cov-2, generation and uses thereofUNIV COLUMBIA·Filed 2021·Application pending·0 cites
- 1165US2023203138A1Potent neutralizing antibodies against sars-cov-2, generation and uses thereofUNIV COLUMBIA·Filed 2021·Application pending·0 cites
- 1259US12098187B2Bispecific HIV-1-neutralizing antibodiesUNIV COLUMBIA·Filed 2018·Granted Sep 24, 2024·0 cites·3 claims
- 1358US2025367225A17dw8-5 treatment for covid-19 and other virus-induced respiratory infectionsUNIV COLUMBIA·Filed 2023·Application pending·0 cites
- 1457US2024343781A1Characterization of potent and broadly neutralizing monoclonal antibodies against sars-cov-2, its variants, and related coronaviruses and methods of useUNIV COLUMBIA·Filed 2022·Application pending·0 cites
- 1556US8852600B2Codon-optimized DNA molecules encoding the receptor binding domains of Clostridium difficile toxins A and B, and methods of use thereofGARDINER DAVID F·Filed 2007·Granted Oct 7, 2014·1 cites·1 claims
- 1654US2024228594A1Antibodies for the treatment and prevention of covid-19 and emerging variantsUNIV COLUMBIA·Filed 2022·Application pending·0 cites
- 1752US2009227658A1Methods and compositions for immunization against hivHUANG YAOXING·Filed 2003·Application pending·0 cites
- 1844US10654943B2Tri-specific antibodies for HIV therapyUNIV ROCKEFELLER·Filed 2016·Granted May 19, 2020·0 cites·8 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →